We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUCK
826
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$9.37M 0.02%
930,961
THC icon
827
Tenet Healthcare
THC
$20.1B
$9.35M 0.02%
191,613
+52,658
+38% +$2.43M
MPC icon
828
Marathon Petroleum
MPC
$90.3B
$9.33M 0.02%
80,119
-153,791
-66% -$17.5M
VLO icon
829
PUT
Valero Energy
VLO
$89.8B
$9.32M 0.02%
73,500
+5,900
+9% +$741K
PHYT
830
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$9.3M 0.02%
900,400
ASML icon
831
CALL
ASML
ASML
$675B
$9.29M 0.02%
+17,000
New +$8.9M
INTC icon
832
CALL
Intel
INTC
$466B
$9.28M 0.02%
351,100
+132,700
+61% +$3.69M
DNAB
833
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$9.24M 0.02%
917,979
AVAC
834
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$9.19M 0.02%
896,363
AFYA icon
835
Afya
AFYA
$1.27B
$9.16M 0.02%
586,147
+152,595
+35% +$2.27M
ARTE
836
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
$9.13M 0.02%
890,799
GDXJ icon
837
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
$9.11M 0.02%
255,400
-321,500
-56% -$10.6M
JUN
838
DELISTED
Juniper II Corp.
JUN
$9.08M 0.02%
893,291
TBSA
839
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
$9.08M 0.02%
899,985
PORT
840
DELISTED
Southport Acquisition Corporation
PORT
$9.07M 0.02%
891,434
XLV icon
841
State Street Health Care Select Sector SPDR ETF
XLV
$42B
$9.07M 0.02%
66,766
+37,504
+128% +$4.97M
DOCS icon
842
Doximity
DOCS
$3.67B
$9.06M 0.02%
269,972
+164,833
+157% +$5.03M
DEVS
843
DELISTED
DevvStream Corp
DEVS
$9M 0.02%
88,360
ICE icon
844
Intercontinental Exchange
ICE
$82.4B
$8.99M 0.02%
87,663
-63,082
-42% -$6.28M
CWH icon
845
Camping World
CWH
$363M
$8.98M 0.02%
402,474
+150,374
+60% +$3.9M
GOLF icon
846
Acushnet Holdings
GOLF
$6.13B
$8.98M 0.02%
211,502
+185,677
+719% +$8.37M
HRMY icon
847
Harmony Biosciences
HRMY
$2.04B
$8.98M 0.02%
162,906
+141,571
+664% +$7.78M
DALS
848
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$8.97M 0.02%
896,939
EXAI
849
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$8.89M 0.02%
1,667,972
+28,852
+2% +$182K
BGSX
850
DELISTED
Build Acquisition Corp.
BGSX
$8.86M 0.02%
883,818

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.